Get startedLog in
    Picture of CHA Vaccine Research Institute logo

    261780 — CHA Vaccine Research Institute Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for CHA Vaccine Research Institute, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-18,420-6,715-1,749-10,138-16,044
    Depreciation
    Amortisation
    Non-Cash Items13,016996-4,1982,1582,417
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital419114121-6062,155
    Change in Accounts Receivable
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-4,740-5,189-5,293-8,096-11,017
    Capital Expenditures-683-447-291-235-156
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-46,7804,18422,2212,52615,874
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-47,4633,73621,9302,29115,718
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities44,320-116-13,1179,990-5,018
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-7,883-1,5683,5204,186-317